Advertisement TomoTherapy acquires Chengdu Twin Peak Accelerator Technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

TomoTherapy acquires Chengdu Twin Peak Accelerator Technology

TomoTherapy, a manufacturer of the Hi Art treatment system for advanced radiation therapy, has finalized the agreement to acquire privately held linear accelerator manufacturer Chengdu Twin Peak Accelerator Technology based in Chengdu, China.

A linear accelerator is a key component in radiation therapy systems used to create high-energy x-rays for cancer treatments. The linear accelerators designed, developed and manufactured by Twin Peak will be used to supplement TomoTherapy’s existing supply source.

Steve Books, COO of TomoTherapy, said: “With the acquisition of Twin Peak, we are reducing our sole supplier risk associated with our linear accelerator supply, a critical component to the Hi Art treatment system.

“This acquisition will also expand TomoTherapy’s competency in design and manufacturing of linear accelerators which is expected to improve Hi Art system reliability and positively impact margins.”